GE HealthCare Technologies (GEHC) Expected to Announce Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is expected to release its Q1 2026 results before the market opens on Wednesday, April 29th. Analysts expect GE HealthCare Technologies to post earnings of $1.07 per share and revenue of $5.0316 billion for the quarter. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, April 29, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the firm earned $1.45 EPS. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $68.89 on Monday. GE HealthCare Technologies has a fifty-two week low of $66.95 and a fifty-two week high of $89.77. The firm’s 50 day moving average price is $74.65 and its 200 day moving average price is $77.81. The company has a market cap of $31.43 billion, a P/E ratio of 15.11, a PEG ratio of 1.52 and a beta of 1.17. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on GEHC. Mizuho cut their target price on shares of GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Monday, April 13th. Evercore increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. BTIG Research reissued a “buy” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research report on Tuesday, April 21st. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their price objective for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Hold” and an average price target of $89.77.

Institutional Trading of GE HealthCare Technologies

Large investors have recently bought and sold shares of the business. Transamerica Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in GE HealthCare Technologies during the fourth quarter worth $34,000. Zions Bancorporation National Association UT raised its position in GE HealthCare Technologies by 125.1% in the fourth quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock worth $34,000 after acquiring an additional 229 shares in the last quarter. Miller Capital Partners Inc. purchased a new position in GE HealthCare Technologies in the fourth quarter worth $38,000. Finally, Palisade Asset Management LLC acquired a new stake in GE HealthCare Technologies in the third quarter valued at $41,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.